Gevorg Tamamyan, Editor-in-Chief of OncoDaily, President of SIOP Asia and POEM Group, CEO at Immune Oncology Research Institute, Chair of the Department of Hematology and Pediatric Oncology at, shared a post on LinkedIn։
“OncoCorridor | May 18, 2026 | Geneva, Switzerland”
Today is a launch of a Corridor.
A Corridor between war and hope, between diagnosis and treatment, between destruction and survival, between a patient trapped by conflict and a doctor somewhere in the world ready to help.
We are entering a new era of Oncology.
AI is transforming the diagnostics, immunotherapy is changing the survival curves, cellular therapies are curing diseases once thought to be uncurable, precision medicine is advancing faster than ever before.
And today is only the beginning.
Years from now, I hope we will look back at this moment, not as a conference in Geneva, but as the day the global oncology community decided that war would no longer mean the end of treatment.
The day we stopped asking “What can we do?”, and started saying “This is what we will do!”
Other articles featuring Gevorg Tamamyan on OncoDaily.